WordNet
- be a contributing factor; "make things factor into a companys profitability"
- any of the numbers (or symbols) that form a product when multiplied together
- an independent variable in statistics
- anything that contributes causally to a result; "a number of factors determined the outcome"
- consider as relevant when making a decision; "You must factor in the recent developments" (同)factor in, factor out
- resolve into factors; "a quantum computer can factor the number 15" (同)factor in, factor out
- an event known to have happened or something known to have existed; "your fears have no basis in fact"; "how much of the story is fact and how much fiction is hard to tell"
- a concept whose truth can be proved; "scientific hypotheses are not facts"
- a piece of information about circumstances that exist or events that have occurred; "first you must collect all the facts of the case"
- a statement or assertion of verified information about something that is the case or has happened; "he supported his argument with an impressive array of facts"
- of or relating to immunology (同)immunologic
PrepTutorEJDIC
- (…の)『要因』,(…を生み出す)要素《+『in』+『名』(do『ing』)》 / 囲数,約数 / 代理人,《おもに英》仲買人 / =factorize
- 〈C〉『事実』,実際にある(あった)事 / 〈U〉真相,真実(truth) / 《the~》(法律用語で)犯行
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. 血友病患者における第VIIIおよび第IX因子阻害物質 factor viii and factor ix inhibitors in patients with hemophilia
- 2. 直接トロンビン阻害剤および直接Xa因子阻害剤による抗凝固療法 anticoagulation with direct thrombin inhibitors and direct factor xa inhibitors
- 3. 後天性の凝固因子阻害物質 acquired inhibitors of coagulation
- 4. 非血友病患者における遺伝子組換え第VIIa凝固因子の治療使用 therapeutic uses of recombinant coagulation factor viia in non hemophiliacs
- 5. 止血の概要 overview of hemostasis
English Journal
- Complement analysis 2016: Clinical indications, laboratory diagnostics and quality control.
- Prohászka Z1, Nilsson B2, Frazer-Abel A3, Kirschfink M4.
- Immunobiology.Immunobiology.2016 Nov;221(11):1247-58. doi: 10.1016/j.imbio.2016.06.008. Epub 2016 Jul 18.
- In recent years, complement analysis of body fluids and biopsies, going far beyond C3 and C4, has significantly enhanced our understanding of the disease process. Such expanded complement analysis allows for a more precise differential diagnosis and for critical monitoring of complement-targeted the
- PMID 27475991
- TGF-β in Toxoplasmosis: Friend or foe?
- Zare-Bidaki M1, Assar S1, Hakimi H1, Abdollahi SH2, Nosratabadi R3, Kennedy D4, Arababadi MK5.
- Cytokine.Cytokine.2016 Oct;86:29-35. doi: 10.1016/j.cyto.2016.07.002. Epub 2016 Jul 20.
- Toxoplasma gondii (T. gondii) is an obligate intracellular protozoan causing several forms of toxoplasmosis in humans. The main mechanisms that allow the development of the prolonged forms of the disease and its subsequent pathology are yet to be clarified. However, many researchers have hypothesize
- PMID 27449809
- Clinical and immunological consequences of total glucosides of paeony treatment in Sjögren's syndrome: A randomized controlled pilot trial.
- Zhou Y1, Jin L1, Kong F2, Zhang H1, Fang X1, Chen Z1, Wang G1, Li X1, Li X3.
- International immunopharmacology.Int Immunopharmacol.2016 Oct;39:314-9. doi: 10.1016/j.intimp.2016.08.006. Epub 2016 Aug 11.
- BACKGROUND: The total glucosides of paeony (TGP) can inhibit inflammation and alleviate symptoms in autoimmune diseases. This study investigated the clinical and immunological consequences of TGP treatment in patients with primary Sjögren's syndrome (SS).METHODS: We conducted a randomized, double-b
- PMID 27517517
Japanese Journal
- たいまつ米胚芽発酵液のヒト免疫応答に与える作用
- 池脇 信直,園田 徹,中村 雅彦,石附 亨,樋口 元剛,杉本 俊一
- 九州保健福祉大学研究紀要 14, 177-182, 2013-03
- 本研究では、我々が独自に開発したGABA およびIP6 含有たいまつ米胚芽発酵液(T-FRGS)のヒト末梢血単核球(PBMCs) に対する形態変化およびサイトカイン産生能を解析した。その結果、T-FRGS はPBMCs に形態変化(細胞間凝集)を誘導した。さらに、Enzyme immunoassay (EIA) を用いた解析から、T-FRGS はPBMCs からIL-1β、IL-6、IL-8、TN …
- NAID 110009596037
- Detection of Chlamydia trachomatis by Immunological and Genetic Methods in Female Sex Workers and the Local Female Population of Reproductive Age in Mymensingh, Bangladesh
- Hoque Syada Monira,Hossain Md Akram,Paul Shyamal Kumar,Mahmud Md Chand,Ahmed Salma,Mahmud Nasir Uddin,Khan Emily Rahman,Sakib Md Annaz Mus,Ghosh Souvik,Kobayashi Nobumichi
- Japanese Journal of Infectious Diseases 66(3), 256-259, 2013
- … A lower socioeconomic status was considered to be an important risk factor for C. …
- NAID 130003381684
- 全身性強皮症における自己抗体とその臨床的特徴
- 濱口 儒人
- 日本臨床免疫学会会誌 36(3), 139-147, 2013
- … 経過，予後の推測に重要である．SScでみられる自己抗体として代表的なものは抗セントロメア抗体，抗トポイソメラーゼI抗体，抗RNAポリメラーゼ抗体であるが，抗Th/To抗体，抗U3RNP抗体，抗human upstream-binding factor (hUBF）抗体，抗セントリオール抗体，抗U1RNP抗体，抗Ku抗体，抗PM-Scl抗体なども頻度は低いながら特徴的な臨床像を有しているため重要な抗体である．SScでみられる自己抗体の頻度には人種差があり，これは …
- NAID 130003364171
Related Links
- The Journal of Immunological Methods is devoted to covering techniques for: (1) Quantitating and detecting antibodies and/or antigens. (2) Purifying immunoglobulins, lymphokines and other molecules of the immune system. (3 ...
- IMMUNOLOGIC RESEARCH represents a unique medium for the presentation, interpretation, and clarification of complex scientific data. Information is presented in the form of interpretive synthesis reviews, original research articles ...
Related Pictures
★リンクテーブル★
| リンク元 | 「immunomodulator」「免疫因子」「immunologic factor」 |
| 関連記事 | 「fact」「factor」「immunological」「immunologic」 |
「immunomodulator」
「免疫因子」
「immunologic factor」
「fact」
- n.
「factor」
- n.
「immunological」
- 免疫学的な、免疫学の
「immunologic」
- adj.
- 免疫性の
- 関
- immune